ODYY insider filings
Odyssey Health, Inc. — 38 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-07-16. Screen ODYY transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ODYY between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Odyssey Health, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-16 | 4 | Casey Jerome H — Director | Grant/award (A): 300,000 (derivative) @ $0.10 | EDGAR |
| 2024-07-16 | 4 | Gironda Gregory W — Chief Operating Officer | Grant/award (A): 250,000 (derivative) @ $0.10 | EDGAR |
| 2024-07-16 | 4 | REDMOND J MICHAEL — President & CEO, Director | Grant/award (A): 500,000 (derivative) @ $0.10 | EDGAR |
| 2024-07-16 | 4 | RICHARDSON RICKY — Director | Grant/award (A): 300,000 (derivative) @ $0.10 | EDGAR |
| 2024-07-16 | 4 | FARRELL CHRISTINE — Chief Financial Officer | Grant/award (A): 500,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-18 | 4 | Gironda Gregory W — Chief Operating Officer | Grant/award (A): 37,500 (derivative) @ $0.09 | EDGAR |
| 2024-01-18 | 4 | Emerson Erik C. | Grant/award (A): 37,500 (derivative) @ $0.09 | EDGAR |
| 2024-01-16 | 4 | GANDOLFO JOHN P | Grant/award (A): 1,500,000 @ $0.09 · Disposition to issuer (D): 1,500,000 (derivative) @ $0.09 | EDGAR |
| 2024-01-02 | 4 | Emerson Erik C. | Grant/award (A): 200,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-02 | 4 | Gironda Gregory W — Chief Operating Officer | Grant/award (A): 200,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-02 | 4 | Casey Jerome H — Director | Grant/award (A): 250,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-02 | 4 | REDMOND J MICHAEL — President & CEO, Director | Grant/award (A): 500,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-02 | 4 | RICHARDSON RICKY — Director | Grant/award (A): 250,000 (derivative) @ $0.10 | EDGAR |
| 2024-01-02 | 4 | FARRELL CHRISTINE — Chief Financial Officer | Grant/award (A): 500,000 (derivative) @ $0.10 | EDGAR |
| 2023-01-13 | 4 | Casey Jerome H — Director | Grant/award (A): 500,000 (derivative) @ $0.30 | EDGAR |
| 2023-01-13 | 4 | REDMOND J MICHAEL — President & CEO, Director | Grant/award (A): 100,000 (derivative) @ $0.30 · Grant/award (A): 400,000 (derivative) @ $0.30 | EDGAR |
| 2023-01-13 | 4 | RICHARDSON RICKY — Director | Grant/award (A): 500,000 (derivative) @ $0.30 | EDGAR |
| 2023-01-13 | 4 | FARRELL CHRISTINE — CFO | Grant/award (A): 100,000 (derivative) @ $0.30 · Grant/award (A): 400,000 (derivative) @ $0.30 | EDGAR |
| 2023-01-13 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 500,000 (derivative) @ $0.30 | EDGAR |
| 2022-11-23 | 4 | Gironda Gregory W | Grant/award (A): 125,000 (derivative) @ $0.25 · Grant/award (A): 475,000 (derivative) @ $0.25 | EDGAR |
| 2022-11-23 | 4 | Emerson Erik C. | Grant/award (A): 125,000 (derivative) @ $0.25 · Grant/award (A): 475,000 (derivative) @ $0.25 | EDGAR |
| 2022-10-19 | 4 | VANLANDINGHAM JACOB PH.D | Grant/award (A): 1,000,000 (derivative) @ $0.32 | EDGAR |
| 2022-10-19 | 4 | FARRELL CHRISTINE — Chief Financial Officer | Grant/award (A): 500,000 (derivative) @ $0.32 | EDGAR |
| 2022-09-15 | 4 | REDMOND J MICHAEL — President & CEO, Director | Gift (G): 1,500,000 @ $0.16 | EDGAR |
| 2022-06-14 | 4 | VANLANDINGHAM JACOB PH.D | Grant/award (A): 1,000,000 @ $0.23 | EDGAR |
| 2022-06-08 | 4 | VANLANDINGHAM JACOB PH.D | Grant/award (A): 100,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | Conroy Jeffrey X — Director | Grant/award (A): 250,000 (derivative) @ $0.30 · Grant/award (A): 250,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | Casey Jerome H — Director | Grant/award (A): 250,000 (derivative) @ $0.30 · Grant/award (A): 250,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | REDMOND J MICHAEL — President/CEO, Director | Grant/award (A): 375,000 (derivative) @ $0.30 · Grant/award (A): 375,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | RICHARDSON RICKY — Director | Grant/award (A): 250,000 (derivative) @ $0.30 · Grant/award (A): 250,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | FARRELL CHRISTINE — Chief Financial Officer | Grant/award (A): 300,000 (derivative) @ $0.30 · Grant/award (A): 300,000 (derivative) @ $0.30 | EDGAR |
| 2022-06-08 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 250,000 (derivative) @ $0.30 · Grant/award (A): 250,000 (derivative) @ $0.30 | EDGAR |
| 2021-09-16 | 4 | Conroy Jeffrey X — Director | Grant/award (A): 500,000 (derivative) @ $0.45 | EDGAR |
| 2021-09-16 | 4 | Casey Jerome H — Director | Grant/award (A): 500,000 (derivative) @ $0.45 | EDGAR |
| 2021-09-16 | 4 | GANDOLFO JOHN P — Director | Grant/award (A): 500,000 (derivative) @ $0.45 | EDGAR |
| 2021-04-09 | 4 | VANLANDINGHAM JACOB PH.D — Director | Grant/award (A): 1,000,000 (derivative) @ $1.18 | EDGAR |
| 2021-03-01 | 4 | REDMOND J MICHAEL — President/CEO, Director | Grant/award (A): 3,000,000 (derivative) @ $0.18 · Other (J): 15,000,000 (derivative) @ $0.25 | EDGAR |
| 2021-03-01 | 4 | FARRELL CHRISTINE — Chief Financial Officer | Grant/award (A): 1,000,000 (derivative) @ $0.18 | EDGAR |
Recent 8-K events — Odyssey Health, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ODYY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs